1. Home
  2. CRNT vs VYGR Comparison

CRNT vs VYGR Comparison

Compare CRNT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

HOLD

Current Price

$2.11

Market Cap

213.6M

Sector

Technology

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.14

Market Cap

216.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNT
VYGR
Founded
1996
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6M
216.3M
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
CRNT
VYGR
Price
$2.11
$3.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.50
$16.50
AVG Volume (30 Days)
272.1K
376.4K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
$9.11
$34.04
Revenue Next Year
$6.70
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.85
$2.94
52 Week High
$3.29
$5.55

Technical Indicators

Market Signals
Indicator
CRNT
VYGR
Relative Strength Index (RSI) 49.91 41.56
Support Level $2.09 $2.95
Resistance Level $2.14 $3.30
Average True Range (ATR) 0.05 0.13
MACD 0.01 -0.03
Stochastic Oscillator 73.33 21.95

Price Performance

Historical Comparison
CRNT
VYGR

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: